Drug profile · INN
flumethasone pivalate
LOCORTEN
flumethasone pivalate (LOCORTEN) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Drug details — flumethasone pivalate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
flumethasone pivalate (LOCORTEN) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is flumethasone pivalate?
flumethasone pivalate (LOCORTEN) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for flumethasone pivalate?
LOCORTEN is a marketed brand name for flumethasone pivalate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of flumethasone pivalate?
flumethasone pivalate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.